Crescent Capital BDC, Inc. Declares Quarterly Dividend of $0.07 (NASDAQ:CCAP)

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) declared a quarterly dividend on Tuesday, November 12th,Zacks Dividends reports. Shareholders of record on Friday, November 29th will be given a dividend of 0.07 per share on Monday, December 16th. This represents a $0.28 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend is Friday, November 29th.

Crescent Capital BDC has a payout ratio of 82.8% indicating that its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline. Analysts expect Crescent Capital BDC to earn $1.99 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 84.4%.

Crescent Capital BDC Price Performance

Shares of NASDAQ CCAP traded down $0.02 during mid-day trading on Wednesday, reaching $18.79. 124,019 shares of the company were exchanged, compared to its average volume of 132,457. Crescent Capital BDC has a 52 week low of $15.91 and a 52 week high of $19.63. The company’s 50 day moving average price is $18.39 and its 200 day moving average price is $18.40. The stock has a market capitalization of $696.36 million, a PE ratio of 7.37 and a beta of 0.81. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.01. The firm had revenue of $48.95 million during the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a return on equity of 12.20% and a net margin of 47.06%. During the same quarter in the previous year, the company posted $0.56 earnings per share. Sell-side analysts forecast that Crescent Capital BDC will post 2.35 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CCAP has been the topic of a number of recent research reports. Bank of America reduced their price target on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, August 15th. LADENBURG THALM/SH SH initiated coverage on Crescent Capital BDC in a research note on Monday, September 30th. They issued a “buy” rating and a $20.00 target price for the company. Finally, Wells Fargo & Company reduced their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 14th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $19.00.

View Our Latest Report on Crescent Capital BDC

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Recommended Stories

Dividend History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.